Picture of GL Pharm Tech logo

204840 GL Pharm Tech Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for GL Pharm Tech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-3,356-3,734-790-3,749-2,337
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items1,2891,277-2,154537560
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-2,505-1,854-1,366-2,686-4,581
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-2,666-2,271-2,165-3,760-4,648
Capital Expenditures-1,098-1,336-6,445-579-392
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items1,907-5611,0109.19-1,188
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities809-1,897-5,435-570-1,580
Financing Cash Flow Items930-0.979
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities11,0238686,0713,8266,350
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash9,166-3,301-1,549-504122